Details

Autor(en) / Beteiligte

• Yu, Fang
• Pituch, Keenan A
• Maxfield, Molly
• Basena, Elsa
• Geda, Yonas E.
• Pruzin, Jeremy J.
• Coon, David W.
• Shaibi, Gabriel Q

Titel

Alzheimer’s Disease Biomarkers: Roles of Type 2 Diabetes from the HABS‐HD Study

Ist Teil von

• Alzheimer's & dementia, 2023-12, Vol.19 (S15), p.n/a

Erscheinungsjahr

2023

Quelle

Wiley Online Library - AutoHoldings Journals

Beschreibungen/Notizen

• Background Alzheimer’s disease (AD) disproportionately affects Mexican Americans, however, reasons underlying this health disparity remain unknown. Type 2 diabetes (T2D) is a risk factor for AD and may contribute to AD pathogenesis. The purpose of this study was to examine the associations between T2D and AD blood biomarkers among Mexican Americans and non‐Hispanic Whites. Methods This study analyzed baseline data from the Health and Aging Brain Study: Health Disparities (HABS‐HD) that investigated AD differences among Mexican Americans and non‐Hispanic White. HABS‐AD participants were excluded from this study if they had missing data or were outliers (z‐scores >|4|) on a given AD biomarker (N = 1,552 for Aβ42/40 ratio, 1,570 for t‐tau, and 1,553 for NfL). AD biomarkers included plasma Aβ42/42 ratio, total tau (t‐tau), and neurofilament light (NfL) analyzed using Simoa. Predictors were blood glucose, HbA1c, and T2D diagnosis. Data were analyzed with regression analyses controlling for covariates (e.g., demographics, smoking, BMI, health status, diseases, cognition) and treating missing predictor data using Bayesian MCMC estimation. Results Mexican Americans differed significantly from non‐Hispanic Whites in age (66.6±8.7 vs. 69.5±8.6), sex (64.9% female vs. 55.1%), education (9.5±4.6 vs. 15.6±2.5), blood glucose (113.5±36.6 vs. 99.2±17.0), HbA1c (6.33±1.4 vs. 5.51±0.6), T2D diagnosis (35.3% vs. 11.1%), Aβ42/40 ratio (.051±.012 vs. .047±.011), t‐tau (2.56±.95 vs. 2.33±.90), and NfL (16.3±9.5 vs. 20.3±10.3). The models with the covariates and predictors accounted for 6% (p<.001), 15% (p<.001), and 36% (p<.001) of the variation in Aβ42/40 ratio, t‐tau, and NfL, respectively. Blood glucose, HbA1c, and T2D diagnosis were not related to Aβ42/40 ratio and t‐tau but explained 3.7% of the variation in NfL (p<.001). Among non‐Hispanic Whites, blood glucose, HbA1c, and T2D diagnosis were negatively (b = ‐0.09, p<.01, β = ‐0.26), not (b = 0.34, p = .71, β = 0.04), and positively (b = 3.32, p<.01, β = 0.33) associated with NfL, respectively. In contrast, blood glucose and T2D diagnosis were not, while HbA1c was positively (b = 2.31, p<.001, β = 0.26), associated with NfL among Mexican Americans. Conclusion Blood glucose, HbA1c, and T2D may contribute to differences in NfL levels, but not Aβ42/40 ratio and t‐tau, in an ethnicity‐specific manner. Future studies are needed to corroborate our findings in longitudinal cohorts.